TUMOUR ABLATION

This adverse event was reported 16 times

TUMOUR ABLATION is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 PEXIDARTINIB HYDROCHLORIDE 1 0.0014
1 ATROPINE INJECTION, 2 MG 1 0.0007
2 RIPRETINIB 2 0.0004
3 HYDROXYZINE PAMOATE 1 0.0003
4 LEVOCARNITINE 1 0.0003
5 LANREOTIDE ACETATE 1 0.0001
6 PANITUMUMAB 2 0.0001
7 TRIFLURIDINE AND TIPIRACIL 1 0.0001
8 BENRALIZUMAB 1 0.0000
9 NIRAPARIB 1 0.0000
See all drugs enriched for association with TUMOUR ABLATION